The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Epidemiology of candidaemia and invasive candidiasis. A changing face
Abstract
Invasive candidiasis is a leading cause of mortality. Candidaemia is the most common clinical presentation of invasive candidiasis but more that 30% of these infections do not yield positive blood cultures. Candida albicans remains the predominant aetiology, accounting for 50% of all cases. However, there has been an epidemiological shift in the last decades. Some species of Candida different to C. albicans have emerged as an important cause of severe candidaemia as they can exhibit resistance to fluconazole and other antifungal agents. Moreover, there is a different distribution of non C. albicans Candida species in relationship to patients' and hospital characteristics. Thus, Candida parapsilosis has been associated to candidaemia in neonates and young adults. This species usually has an exogenously origin and contaminates medical devices, causing central venous catheter-associated candidaemias. Candida glabrata, Candida tropicalis and Candida krusei are isolated in blood cultures from older patients (>65 years) with important risk factors, such as major abdominal surgery, solid tumours and haematologic malignancies, transplants, and/or prolonged treatment with corticoids. Moreover, important geographical differences in the distribution of the Candida species different to C. albicans causing invasive candidiasis have been reported: C. parapsilosis predominates in Australia, Latin America and Mediterranean countries of Africa, Asia and Europe. In contrast, C. glabrata has an important aetiological role in USA and Central and Northern Europe. Finally, an important and worrying issue is that mortality due to invasive candidiasis remains unacceptably high. This manuscript is part of the series of works presented at the "V International Workshop: Molecular genetic approaches to the study of human pathogenic fungi" (Oaxaca, Mexico, 2012).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although infections with C. albicans are still the most common, epidemiology is shifting towards non-albicans Candida, wherein the specific relative incidences are being time- and space-dependent [30]”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [30]
Citations
Cites
1 retracted
Cisterna, R., Ezpeleta, G., Tellería, O., Guinea, J., Regueiro, B. J., Garcia-Rodríguez, J., & Esperalba, J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00920-10 · Cited by 72
RetractedHajjeh, R. A., Sofair, A. N., Harrison, L. H., Lyon, G. M., Arthington-Skaggs, B. A., Mirza, S. A., Phelan, M., Morgan, J., Lee-Yang, W., Ciblak, M. A., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1519-1527.2004 · Cited by 649
Almirante, B., Rodríguez-Pardo, D., Park, B. J., Cuenca‐Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sánchez, F., Ayats, J., Giménez, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1829-1835.2005 · Cited by 571
Colombo, A. L., Nucci, M., Park, B. J., Nouér, S. A., Arthington, B. A., da Matta, D. A., Warnock, D. W., & Morgan, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00773-06 · Cited by 525
Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509
Kao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457
Diekema, D. J., Messer, S. A., Brueggemann, A. B., Coffman, S. L., Doern, G. V., Herwaldt, L. A., & Pfaller, M. A. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1298-1302.2002 · Cited by 385
Epidemiology of candidemia in Latin America: a laboratory-based survey
Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I. N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M. E., Thompson, L., Sifuentes-Osornio, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059373 · Cited by 374
The Impact of Hospital-Acquired Bloodstream Infections
Wenzel, R. P., & Edmond, M. B. (2001) · Emerging infectious diseases · doi:10.3201/eid0702.010203 · Cited by 359
Candidaemia in Europe: epidemiology and resistance
Tortorano, A. M., Kibbler, C. C., Pemán, J., Bernhardt, H., Klingspor, L., & Grillot, R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.01.002 · Cited by 349
Cited by
Sorted by citations
Cornely, O. A., Sprute, R., Bassetti, M., Chen, W., Groll, A. H., Kurzai, O., Lass‐Flörl, C., Ostrosky-Zeichner, L. L., Rautemaa‐Richardson, R., Revathi, G., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00749-7 · Cited by 458
Candida parapsilosis: from genes to the bedside
Tóth, R., Nosek, J., Mora-Montes, H. M., Gabaldon, T., Bliss, J. M., Nosanchuk, J. D., Turner, S. A., Butler, G., Vágvölgyi, C., & Gácser, A. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-18 · Cited by 327
Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens
Ksiezopolska, E., & Gabaldón, T. (2018) · Genes · doi:10.3390/genes9090461 · Cited by 230
Costa-de-Oliveira, S., & Rodrigues, A. G. (2020) · Microorganisms · doi:10.3390/microorganisms8020154 · Cited by 229
Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?
Voltan, A. R., Quindós, G., Medina‐Alarcón, K. P., Fusco‐Almeida, A. M., Mendes‐Giannini, M. J. S., & Chorilli, M. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s93105 · Cited by 125
Self-citation
Metadata
- Authors
- Quindós, G.
- Affiliations
- University of the Basque Country (ES)
- Corresponding author
- Quindós, Guillermo
- ORCID
- Quindós, Guillermo
- Venue
- Revista Iberoamericana de Micología
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 31
- Issue
- 1
- Pages
- 42-48
- ISSN
- 1130-1406 (ISSN-L)
- OpenAlex
- W1993370685
- Cited by
- 219
- References
- 68
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 12 · 2023: 9 · 2022: 20 · 2021: 19 · 2020: 17 · 2019: 16 · 2018: 28 · 2017: 22 · 2016: 20 · 2015: 24 · 2014: 10
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Revista Iberoamericana de Micología (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- invasive candidiasis, candidemia, non-albicans Candida, Candida albicans, Candida parapsilosis, Candida glabrata, Candida tropicalis, Candida krusei, fluconazole resistance, antifungal resistance, risk factors
- MeSH terms
- Adult, Candida, Child, Cross Infection, Female, Humans, Infant, Infant, Newborn, Male, Morbidity, Species Specificity, Global Health, Incidence, Age Distribution, Sex Distribution, Young Adult, Candidiasis, Invasive, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review